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Expression of cytoskeleton and energetic
metabolism-related proteins at human abdominal
aortic aneurysm sites
Javier Modrego, PhD,a Antonio J. López-Farré, PhD,a Isaac Martínez-López, MD,b
Miguel Muela, MD,b Carlos Macaya, MD, PhD,a Javier Serrano, MD, PhD,b and
Guillermo Moñux, MD, PhD,b San Carlos, Madrid, Spain
Objective: The purpose of this study was to evaluate the expression of proteins related to cytoskeleton and energetic
metabolism at abdominal aortic aneurysm (AAA) sites using proteomics. Several remodeling-related mechanisms have
been associated with AAA formation but less is known about the expression of proteins associated with cytoskeleton and
energetic metabolism in AAAs.
Methods: AAA samples (6.73  0.40 cm size) were obtained from 13 patients during elective aneurysm repair. Control
abdominal aortic samples were obtained from 12 organ donors. Proteins were analyzed using two-dimensional
electrophoresis and mass spectrometry.
Results: The expression of filamin was increased in the AAA site compared to control abdominal aortic samples while
microfibril-associated glycoprotein-4 isotype 1, annexin A5 isotype 1, and annexin A2 were reduced compared with
control abdominal aortic samples. Reduction in expression level of energetic metabolism-associated proteins such as
triosephosphate isomerase, glyceraldehyde 3-phosphate dehydrogenase, and cytosolic aldehyde dehydrogenase was also
observed in AAAs compared to controls. Reduction of triosephosphate isomerase expression was also observed by
Western blot, which was accompanied by diminished triosephosphate isomerase activity. At the AAA site, pyruvate
dehydrogenase expression was reduced and the content of both lactate and pyruvate was increased with respect to controls
without changes in lactate dehydrogenase activity.
Conclusions: The present results suggest that an anaerobic metabolic state may be favored further to reduce the expression
of cytoskeleton-related proteins. The better knowledge of molecular mechanism involved in AAAs may favor develop-
ment of new clinical strategies. ( J Vasc Surg 2012;55:1124-33.)
Clinical Relevance:The present study shows the possibility of promotion of anaerobic metabolism at human abdominal aortic
aneurysm (AAA) sites in addition to providing new data about reduction in the expression of cytoskeleton-related proteins in
AAAs, which could be involved in abdominal aortic aneurysm distensibility and rupture. These findings could help to know
more indepth undescribed molecular mechanisms associated with AAAs and may favor development of new clinical strategies.
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strongly associatedwith systemic atherosclerosis; the dilatative
manifestation of an AAA is the opposite to the characteristic
occlusion of atherosclerotic disease. Different findings have
demonstrated that degradation and remodeling of extracellu-
lar matrix accompanied by chronic inflammation and endo-
thelial alterations are processes associated with aneurysm for-
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1124ation, although other important processes involved in
ascular physiology remains to be analyzed.1,2
Evidence has suggested that maintenance of vascular
unction is particularly dependent on vascular energetic
etabolism.3 Indeed, the arterial wall is supplied with
xygen and nutrients by diffusion and convection from
uminal blood and from vasa vasorum in the adventitia and
uter media. Indeed, aerobic glycolysis is considered char-
cteristic of the metabolism in the normal aortic wall.4
owever, it has been speculated that the existence of an
ncreased glucosemetabolism in AAA5 depends onwhether
roteins are involved in energetic metabolism, particularly
hose involved in the glycolytic pathway, and if they can be
ltered at the aneurysmal site remains to be explored.
Cytoskeleton is another critical component of the vas-
ular wall because it is important for the maintenance of
ascular integrity.6 The role of extracellular matrix compo-
ents have been extensively studied in AAA,7,8 but to the
est of our knowledge, relatively little attention has been
aid to vascular cytoskeleton-related proteins.
Until now, it has been difficult to monitor changes in
he expression of several proteins associated with a specific
olecular pathway at the same time in a single sample.
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Volume 55, Number 4 Modrego et al 1125However, an alternative approach is the analysis of protein
expression patterns in the use of two-dimensional electro-
phoresis (2-DE) in combination with mass spectrometry
which has been termed as proteomics. Therefore, our aim
was to analyze, using proteomics, the level expression of
proteins associated with energetic metabolism and cyto-
skeleton in human AAAs compared with those in abdomi-
nal aortic control samples.
METHODS
Aortic samples collection. AAAs were obtained dur-
ing elective aneurysm repair from 13 patients. AAA samples
were obtained from the more dilated portion of the infra-
renal aorta (5 cm). Patients were excluded if they pre-
sented Marfan syndrome, systemic inflammatory diseases,
oncological disease, or have had any surgical procedure
within the last 6 months before inclusion. The presence of
thoracic aortic dilatation was discarded by computed to-
mography, which was also used to determine abdominal
aortic diameter. Control abdominal aortic samples (nonan-
eurysmal abdominal aortic wall samples) were obtained
from 12 organ donors during clinical transplantation. The
grafts were derived from organ donors with brain injury
caused by amajor head trauma. Aortic control samples were
obtained at the level of the renal artery and the aortic
diameter was determined before aortic extraction using a
surgical caliper. Aortic samples were immediately cleaned of
blood, fat, and foreign tissues washed in isotonic saline and
quickly frozen at 80°C until proteomic determination.
The aortic samples were obtained after signed consent
of the patients, and in the case of organ donors, after family
consent. The protocol was approved by our local ethics
committee.
Two-dimensional electrophoresis and image analysis.
Human aortic samples were homogenized with an Ultra-
Turrax T8 (IKA-Werke; GmbH & Co, Staufen, Germany)
homogenized in a buffer containing 8 mol/L urea, 2%
CHAPS w/v, 40 mmol/L dithiothreitol, 0.2% Bio-
LyteTH ampholyte (Bio-Rad Laboratories, Hercules,
Calif), and 0.01% w/v bromophenol blue. The homoge-
nate tissues were centrifuged at 10,000 g for 10 minutes
and the supernatant stored at80°C until further analysis.
Protein quantification was done by bicinchoninic acid re-
agent (Pierce, Rockford, Ill). Two hundred fifty g of total
protein was loaded onto each gel on immobilized pH
gradient strips (pH 3-10) and isoelectric focusing was
performed using a Protean IEF cell system (Bio-Rad Lab-
oratories) as reported.8,9 The gels were actively rehydrated
at 50V for 60 hours, then rapid and linear voltage ramping
steps were used, limited by a maximum current of 50 A
per gel. The remaining protein was used for Western blot-
ting and enzymatic assays. In the second dimension, the
proteins from the strips were resolved on 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) gels using a Protean II XL system (Bio-Rad Labo-
ratories).9,10 After electrophoresis, the gels were fixed and
silver stained. The silver staining was done following the ranufacturer’s recommendations using a Silver Stain Plus
it (Bio-Rad Laboratories).
The stained gels were scanned in a UMAX POWER-
OOK III scanner (Dallas, Tex) operated by the software
agic Scan version 4.5. Intensity calibration was carried out
sing an intensity stepwedge before gel image capture. Image
nalysis was carried out using Quantity One 4.2.3 (Bio-Rad
aboratories). Image spots were initially detected, matched,
nd then manually edited. Each spot intensity volume was
rocessed by background subtraction.
Mass spectrometry. Protein features chosen for mass
pectrometric analysis were manually excised from the gels
sing biopsy punches and were digested with tryp-
in10,11. The peptides extracted with 100 mmol/L am-
onium bicarbonate and purified using mmol/L-18 Zip
ips (Millipore, Billerica, Mass). For mass spectrometry
MS) analysis, 1 L of purified extracts was mixed with 1
L of -cyano-4-hydroxytrans cinnamic matrix (Sigma,
t. Louis, Mo) in 50% acetonitrile, 0.1% trifluoroacetic
cid, and 1 L of this mixture was spotted onto a Maldi
late. MS analyses were performed in a 4700 Proteomic
nalyzer (Applied Biosystems, Austin, Tex) and operated
n a reflector positive mode. All mass spectra were calibrated
sing a standard peptide mixture (Applied Biosystems). Au-
omated analysis of mass data was achieved by using the 4000
eries Explorer Software (Applied Biosystems) and MS/MS
pectra data were combined through the GPS Explorer Soft-
are (Applied Biosystem). The analysis in an MS mode pro-
uced peptide mass fingerprints, and some peptides observed
ere further analyzed in an MS/MS mode as previously
eported.9-11 Peptideswith a signal-to-noise ratio greater than
0 were considered in the Mascot Database for protein iden-
ification. For protein identification, Mascot database 1.9
http://www.matrixscience.com) was used as the algorithm
omatch the peptides obtainedbyMS.TheMS identifications
ere accepted based on a tripartite evaluation that takes into
ccount significant molecular weight search (Mowse) scores,
pectrum annotation, and observed vs expected migration on
he 2-DE gel.
Western blot analysis. Protein expression of triose-
hosphate isomerase and pyruvate dehydrogenase was an-
lyzed by Western blot. In brief, the homogenized vascular
egments were solubilized in Laemmli buffer containing
-mercaptoethanol. The obtained proteins were separated
n denaturing SDS-PAGE 15% (w/v) polyacrylamide gels.
qual amount of proteins (20 g/lane), estimated by
icinchoninic acid reagent (Pierce), were loaded. To assess
hat the same amount of proteins were loaded into the gel,
parallel gel with identical samples was run and stained
ith Coomassie. As reported,11 proteins were blotted onto
itrocellulose (Immobilion-P; Millipore) and the blots
ere blocked overnight at 4°C with 5% (w/v) nonfat dry
ilk. Membranes were then incubated with monoclonal
ntibodies against either triosephosphate isomerase (1:
000; Santa Cruz Biotechnology, Santa Cruz, Calif) or
yruvate dehydrogenase (1:1000; Santa Cruz Biotechnol-
gy). Afterward, membranes were incubated with horse-
adish peroxidase (HRP)-conjugated anti-(mouse, rabbit,
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April 20121126 Modrego et alor goat immunoglobulin G [IgG]) antibodies at a dilution
of 1:2000. Proteins were detected by enhanced chemilumi-
nescence (ECL; Amersham Biosciences, Uppsala, Sweden)
and evaluated by densitometry (Quantity One; Bio-Rad
Laboratories). Prestained protein markers (Sigma) were
used for molecular mass determinations.
Determination of fructose 1,6-bisphosphate aldolase,
triosephosphate isomerase, and lactate dehydrogenase
activities. The activity of both fructose 1,6-bisphosphate al-
dolase and triosephosphate isomerase was determined in the
abdominal aortic samples following the method described by
Misset and Opperdoes.12 In brief, 240 g of total protein
from the aortic samples were incubated in 100 mmol/L
Tris-HCl buffer pH 7.4 (T-1503; Sigma-Aldrich, St. Louis,
Mo), 58 mmol/L fructose 1,6-diphosphate solution (F-
0752; Sigma-Aldrich), 4.0mmol/L-nicotinamide adenine
dinucleotide reduced form (N-8129; Sigma-Aldrich), and
50 units/mL of -glycerophosphate dehydrogenase/tri-
osephosphate isomerase (G-6755; Sigma-Aldrich) for aldo-
lase assay. Aldolase activity was assayed at 340 nm at 25°C
using plastic cuvettes.
The same amount of total aortic protein was used for the
determination of triosephosphate isomerase activity. Aortic
samples were incubated in 100 mmol/L Tris-HCl buffer pH
7.4 (T-1503; Sigma-Aldrich), 58 mmol/L glyceraldehyde-3-
phosphate solution (G-5251; Sigma-Aldrich), 4.0 mmol/L
-nicotinamide adenine dinucleotide reduced form (N-
8129; Sigma-Aldrich) and 50 units/mL of -glycerophos-
phate dehydrogenase/aldolase (A-2714; Sigma-Aldrich).
Triosephosphate isomerase activity was assayed at 340 nm
at 25°C using plastic cuvettes. Triosephosphate isomerase
and 1,6-biphosphate aldolase activities were determined
before and 5minutes after the aortic samples were added to
reaction.
Lactate dehydrogenase activity was determined in the
abdominal aortic sample (0,1 g aortic tissue/sample) using
a commercial kit (K-726-500; BioVision Research Prod-
ucts, Mountain View, Calif) following the manufacturer’s
recommendations.
Determination of pyruvate and lactate content in
the aortic samples. The content of pyruvate and lactate in
the human aortic samples was determined using a pyruvate
Table I. Clinical features of AAA patients and organ dono
Parameters AAA (n  13
Age, years 69.31  4.38
Male/female 11/2
AAA size, cm 6.73  0.4
Intraluminal mural thrombus 13/13
Risk factors
Smoking history 12/13
Hypertension 8/13
Dislipemia 7/13
Diabetes mellitus 2/13
AAA, Abdominal aortic aneurysm.
Age and AAA size are represented as means  SEM.and lactate assay kits (K609-100 and K607-100; BioVision mesearch Products) following the manufacturer’s instruc-
ions.
Statistical methods. Results are expressed as mean 
EM. To control the potential effect of age, simple and
ultivariate linear regression analyses were performed. The
xpression level of each protein was considered a response
ariable and the aortic disease status (AAA 1 or control
) was considered an independent variable. Age was used as
covariate in the multivariate model.
ESULTS
The clinical features of the patients with AAAs and
ontrols are shown in Table I. There were no statistical
ifferences in clinical features as gender or risk factors
etween AAAs and organ donor patients except for the
resence of intraluminal mural thrombus in the patients
ith AAAs, which was not observed in any of the aortic
amples obtained from organ donors. Age was significantly
igher in patients with AAAs than in organ donors (P 	
001; Table I). All the included AAAs showed intraluminal
ural thrombus determined by computed tomography
can. Before the proteomic study was performed, the
hrombus was removed and the abdominal aortic samples
ere washed with isotonic saline. In the proteomic maps,
pots were densitometrically analyzed and identified by
omparison with those found published in human ascend-
ng aorta.13 Spots in which differences were observed be-
ween AAAs and control samples were further identified by
ass spectrometry (Fig 1). This work was focused in the
tudy of proteins associated with cytoskeleton and ener-
etic metabolism.
Differences in proteins associated with the cytoskel-
ton between abdominal aortic aneurysms and control
ortic samples. The following proteins associated with the
ytoskeleton were identified in the abdominal aortic pro-
eome: (1) 
/-actin: (2) filamin; (3) two microfibril-
ssociated glycoprotein IV isotypes; (4) two tropomyosin
-chain isotypes; (5) vimentin; (6) two annexin five iso-
ypes; (7) annexin A2 (Table II; Fig 2).
A significant reduction in the expression of the follow-
ng cytoskeleton-related proteins was observed at the AAA
ite with respect to control abdominal aortic samples:
m who abdominal aortic samples were obtained
Controls (n  12) P value
53.91  8.30 .001
9/3 —
	2 .001
— —
10/12 —
7/12 —
8/12 —
0/12 —rs fro
)icrofibril-associated glycoprotein-IV isotype one, an-
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Fig 1. Mass spectrometry (MS) and tandem mass spectrometry spectra (MS/MS) to identify proteins. Spectra of triose-
phosphate isomerase, glyceraldehyde-3-phosphate dehydrogenase, and annexin A2. Thematched peptides are shown in the
figure for each specific protein and they were analyzed using the Mascot database (http://www.matrixscience.
com) for the identity of each protein.Table II. Expression of cytoskeleton-related proteins at the AAA site and in control abdominal aortic samples
Protein Controls (n  12) AAA (n  13) Age adjusted P valuea

/-actin 2316.25  391.75 1113.31  210.04 .499
Filamin 250.00  43.45 390.34  78.36 .041
Microfibril-associated glycoprotein 4
Isotype 1 155.29  44.41 32.31  13.77 .016
Isotype 2 144.04  28.59 67.14  29.46 .293
Tropomyosin  chain
Isotype 1 206.90  86.35 171.14  72.82 .145
Isotype 2 837.72  180.97 240.86  44.06 .217
Vimentin 141.09  12.27 83.45  16.09 .175
Annexin 5
Isotype 1 430.66  40.51 259.75  33.1 .012
Isotype 2 149.86  26.83 132.49  23.80 .401
Annexin A2 192.20  34.70 59.92  15.58 .018
AAA, Abdominal aortic aneurysm.
aP values are calculated in lineal regression equations where the protein expression was the dependent variable. The disease status (AAA vs control) was the
independent parameter. Age was used as covariant into the model to give adjusted P values. Results are represented as mean  SEM. A P value 	.05 was
considered statistically significant.
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April 20121128 Modrego et alnexin A5 isotype one, and annexin A2 (Table II). More-
over, the protein expression level of filamin was found
increased in AAAs with respect to that in the controls
(Table II).
Changes in the expression of energetic metabolism-
related proteins between abdominal aortic aneurysms
and control aortic samples. The following proteins asso-
ciated with the energetic metabolism were identified in the
Fig 2. Representative bidimensional gel electrophoresi
developed using a pH range between 3 and 10. In the gel
representative spots of cytoskeleton and energetic metab
was found between the abdominal aortic aneurysm (AA
Table III. Expression of energetic metabolism-related pro
Protein Controls (
Triosephosphate isomerase 104.17 
Glyceraldehyde-3-phosphate dehydrogenase 199.41 
Cytosolic aldehyde dehydrogenase 180.79 
-Enolase
Isotype 1 70.24 
Isotype 2 114.81 
Lactate dehydrogenase 134.30 
Phosphoglycerate mutase 166.35 
Mitochondria aldehyde dehydrogenase
Isotype 1 268.24 
Isotype 2 299.24 
ATP synthase -chain 72.94 
AAA, Abdominal aortic aneurysm.
aP values are calculated in lineal regression equations where the protein exp
independent parameter. Age was used as covariant into the model to give a
considered statistically significant.abdominal aortic proteome: (1) triosephosphate isomerase; t2) glyceraldehyde 3-phosphate dehydrogenase; (3) two
-enolase isotypes; (4) lactate dehydrogenase; (5) phos-
hoglycerate mutase; (6) two mitochondrial aldehyde de-
ydrogenase isotypes; (7) cytosolic aldehyde dehydroge-
ase, and (8) adenosine triphosphate (ATP) synthase
-chain (Table III; Fig 2).
In AAA samples, the level of expression of triosephos-
hate isomerase was significantly reduced with respect to
E) of an abdominal aortic proteome. Proteomes were
rked the spots that were analyzed. On the right is shown
-related proteins in which a different level of expression
e and control abdominal aortic samples.
at AAA site and in control abdominal aortic samples
2) AAA (n  13) Age adjusted P valuea
1 55.28  16.21 .045
0 114.05  25.89 .007
9 83.90  27.54 .037
7 75.59  8.35 .348
7 100.32  16.38 .400
9 123.46  30.60 .501
5 132.43  29.38 .899
8 176.47  27.54 .327
1 210.49  40.51 .680
1 63.13  11.58 .677
n was the dependent variable. The disease status (AAA vs control) was the
d P values. Results are represented as mean  SEM. A P value 	 .05 wass (2-D
is ma
olismteins
n  1
12.6
24.4
31.3
10.5
19.1
28.2
31.8
44.9
44.2
13.9
ressio
djustehat in control abdominal aortic samples (Table III). It was
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Volume 55, Number 4 Modrego et al 1129confirmed by Western blot experiments, which showed
reduction in the expression of triosephosphate isomerase in
AAAs with respect to controls (Fig 3). It was accompanied
by reduction in triosephosphate isomerase activity (Fig 4).
The activity of another key-step-associated glycolytic en-
zyme, 1,6 biphosphate aldolase, was not modified in AAA
samples with respect to control (Fig 4).
In the aortic proteomic map, the expression of both
glyceraldehyde-3-phosphate dehydrogenase and cytosolic
aldehyde dehydrogenase was significantly reduced at the
AAA site compared with those in control (Table III). The
level of expression of other identified proteins involved in
the energetic metabolism, such as mitochondrial aldehyde
dehydrogenase isotypes one and two, ATP synthase
-chain, -enolase isotypes one and two, and lactate dehy-
drogenase, was not different between AAAs and control
samples (Table III).
The aortic content of both pyruvate and lactate was also
determined. As Fig 4 shows, lactate content was signifi-
cantly increased at the AAA site with respect to that in
control abdominal aortic samples. However, lactate dehy-
drogenase activity was not modified between AAA site and
control (Fig 5). Moreover, the aortic content of pyruvate
was also significantly increased in AAAs compared with
Fig 3. Representative Western blots of triosephosphate
densitometric analysis in arbitrary units (AU) of the We
linear regression using age as covariant. The protein ex
independent variable. Densitometric values are represent
Abdominal aortic aneurysm.controls (Fig 4). Western blot analysis showed a diminished axpression of pyruvate dehydrogenase in AAAs with respect
o control samples (Fig 3).
Statin treatment and changes in the expression of
roteins in the abdominal aortic aneurysm site. In the
ncluded patients with AAAs (n 13), 5 of them had been
reated with statins for more than 1 year before the surgery
ntervention and 8 of them were not taking statins.
As Table IV shows, proteins that showed a different
evel of expression between abdominal aortic samples from
ontrols and patients with AAAs were not statistically dif-
erent in their level of protein expression between patients
ith AAAs taking and not taking statins at inclusion. Un-
ortunately, it was not possible to analyze if some of the
ontrol donors were taking statins because the donor pro-
ess is completely anonymous and all clinical data are under
rotection.
ISCUSSION
The present study shows that at the AAA site there is a
ifferent level of expression of proteins associated with the
ytoskeleton and with the glycolytic pathway than those
bserved in control abdominal aortic samples.
Cytoskeleton-related proteins at the abdominal
ortic aneurysm site. Our first observation was that in
erase and pyruvate dehydrogenase. Bar graphs show the
blots. The densitometric analysis was performed using
on as response variable and the aortic disease status as
mean  SEM. *P 	 .05 with respect to control. AAA,isom
stern
pressi
ed asn AAA, the level of expression of some cytoskeleton-
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April 20121130 Modrego et alrelated proteins, including microfibril-associated glyco-
protein four isotype one, annexin five isotype one, and
annexin A2, was reduced with respect to that found in
Fig 4. Enzymatic activities and metabolites measures o
1,6 biphosphate aldolase and triosephosphate isomeras
abdominal aortic aneurysm (AAA) site. At the bottom i
control abdominal aortic samples. Enzymatic activity an
variable, aortic disease status as independent variable and
SEM. *P 	 .05.
Fig 5. Enzymatic activity of lactate dehydrogenase. The enzy-
matic activity was determined in time 0 and 30 minutes after add
the homogenate tissue to reactive reagents as manufacturer’s rec-
ommended. Lactate dehydrogenase activity was used as response
variable, aortic state as independent value, and age as covariant in
the linear regression model. Results are mean  SEM. AAA,
Abdominal aortic aneurysm.the controls. sMoreover, annexins have been identified as important
egulators of the hemostatic balance. Both annexin A5 and
nnexin A2 have also been associated with antithrombotic
roperties, including reduction of thrombus forma-
ion.14,15 In this regard, the presence of intraluminal mural
hrombus is usually observed in AAAs, as also occurred with
ur included AAA samples. Therefore, reduction in the
evel of expression of both annexin five isotype one and
nnexin A2 in AAAs together with other putative involved
actors16 may promote the presence of intraluminal mural
hrombus in AAAs, which has been associated with AAA
uptures.17 It is remarkable that at the aneurysmal site,
ntraluminal mural thrombus may also be involved by itself
s a regulator of the level of expression of proteins in the
ortic wall. In this regard, we recently observed that plate-
ets down-expressed annexin A5 isotype in bovine aortic
egments supporting a close relationship between blood
lements and the vascular expression of annexins.18
In addition to its antithrombotic properties, annexin
5 has been proposed as a potential tracer for vascular
poptosis.19 A close relationship between AAAs and the
poptotic phenomenon has been also reported.20
The level of expression of microfibril-associated glyco-
rotein four was also reduced at the AAA site compared
ith control abdominal aortic samples. Other contractile-
elated proteins also tended to show a lower level of expres-
step glycolytic enzymes. On the top is shown graphs of
ivities in control abdominal aortic sample and at the
wn pyruvate and lactate content at the AAA site and in
uvate and lactate content were considered as response
as used as covariant. Results are represented as meanf key-
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s sho
d pyr
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Volume 55, Number 4 Modrego et al 1131reach statistical significance. The reduction in the level of
expression of these cytoskeleton-related proteins in AAAs
may be in accordance with a decreased vascular distensibil-
ity reported by other authors.21,22
The fact that filamin, an actin-crosslinking filament
protein, was up-expressed at the AAA site may be a coun-
terbalance effect trying to prevent the decreased vascular
contractibility and distensibility related to AAAs. In this
regard, null and missense mutation in filamin were associ-
ated with malformations, including loss of vascular disten-
sibility.23
Energetic metabolism-related proteins at the ab-
dominal aortic aneurysm site. Glucose metabolism is an
important determinant of vascular reactivity.24 In the pro-
teomic map, the level of expression of triosephosphate
isomerase, a glycolytic key-step enzyme, was significantly
reduced at the AAA site with respect to that observed in
control abdominal aortic samples. This finding was further
assessed by Western blot experiments. In addition, the
decreased expression of triosephosphate isomerase in AAAs
was accompanied by the reduction of its activity. The
protein expression of another important glycolytic enzyme,
glyceraldehyde-3-phosphate dehydrogenase, was also re-
duced in AAAs with respect to that found in controls.
Several considerations should be raised about these
findings. The first is that, to the best of our knowledge, few
data are available in the scientific literature about the ener-
getic metabolism in AAAs. In this regard, it has been
speculated, using positron emission tomography, that in-
creased glucose uptake occurs within the aneurysmal
wall.5,25 This increased glucose uptake by AAA could seem
contrary to our findings; however, the increased glucose
uptake at the site of the aortic aneurysm may be a compen-
satory mechanism for the reduction of either triosephos-
phate isomerase and glyceraldehyde-3-phosphate dehydro-
genase here observed at the aneurysmal site.
A key branch point in the glycolytic pathway is the
production of pyruvate which, in normoxia, is metabolized
by pyruvate dehydrogenase to acetyl-CoA, the first step in
the tricarboxylic acid cycle. At the AAA site, pyruvate
dehydrogenase expression was reduced compared with that
Table IV. Differences in the expression level of proteins b
Taking statins a
Filamin 208.13
Microfibril-associated glycoprotein 4 isotype 1 28.88
Annexin 5 isotype 1 308.00
Annexin A2 45.91
Triosephosphate isomerase 24.66
Glyceraldehyde-3-phosphate dehydrogenase 129.57
Cytosolic aldehyde dehydrogenase 90.19
AAAs, Abdominal aortic aneurysms.
Mann-Whitney test was used to determine statistical differences between pat
as mean  SEM. A P value 	.05 was considered statistically significant.found in the abdominal aortic control samples, which was wccompanied by an increased content of both pyruvate and
actate at the AAA site. Because in anaerobic conditions
yruvate is catabolized to lactate, these findings may sug-
est that at the AAA site anaerobic metabolism may be
avored.
In normal human aorta, the regular geometry results in
aminar blood flow and in homogeneous shear rate, main-
aining a physiological steady-state among the blood com-
onents and arterial wall. Changes in arterial geometry may
odify rheological parameters favoring low wall shear rate
nd even reduce the vascular oxygen content.26 In this
egard, Vorp et al27 have hypothesized a poor diffusion of
xygen related to intraluminal thrombus within AAAs lead-
ng to local hypoxia, which may be in accordance with
romoting anaerobic metabolism.
The increased lactate content in AAAs was produced
ithout changes in lactate dehydrogenase expression,
hich may suggest an increased activity of this enzyme.
owever, lactate dehydrogenase activity was not different
etween the aortic samples from control donors and pa-
ients with AAAs. In this regard, pyruvate dehydrogenase
eficiency has been associated with lactic acidosis.28 Taken
ogether, it may suggest that reduction in pyruvate dehy-
rogenase expression at theAAA sitemay direct pyruvate into
actate with no modification in lactate dehydrogenase activity
ut promoting an anaerobic state. Moreover, the increased
ontent of pyruvate found in AAAs may be explained by the
arked decrease in pyruvate dehydrogenase expression ob-
erved in AAAs, whichmay facilitate pyruvate accumulation in
ddition to increased lactate formation.
The level of expression of cytosolic aldehyde dehydro-
enase was also reduced at the aneurysmal site. Cytosolic
ldehyde dehydrogenase, further to oxidate aldehyde to car-
oxylic acids, catalyzes the formation of 1,2-glycerol dinitrate
nd nitrite from nitroglycerin leading cyclic guanylate
onophosphate-dependent vasorelaxation.29 To our
nowledge, there are nonreported data about vasoreactivity
f AAAs in response to nitrovasodilators, although we
annot discard that the changes observed in the cytosolic
ldehyde dehydrogenase in AAAs may be in accordance
en patients with AAAs taking and not taking statins
Patients with abdominal aortic aneurysm
sion (n  5) Not taking statins at inclusion (n  8) P value
.49 481.45  102.43 .073
.02 34.77  19.57 .931
.15 225.29  32.74 .291
.63 69.92  25.43 .806
06 73.66  22.49 .180
.72 102.96  37.15 .464
.39 80.75  24.83 .496
ith AAAs taking and not taking statins at inclusion. Results are representedetwe
t inclu
 44
 21
 63
 12
 4.
 37
 13ith the reduced distensibility reported by other authors.
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cytoskeleton-related proteins and the expression of glyco-
lytic-related enzymes in AAAs may be related to the other.
Breakdown of microtubules and other cytoskeleton-related
proteins has been shown to decrease the content of key
glycolytic enzymes in cardiomyocytes.30 It is difficult to
know if both processes occur dependently or independently
between them. However, both reduction in cytoskeleton-
related proteins and glycolytic enzymes may both contrib-
ute to vascular distensibility in AAAs.
Study limitations. The present experimental design
did not allow us to assess the clinical relevance of the
present findings. However, as speculation, it is possible that
changes in the expression of cytoskeleton-related proteins
and a putative anaerobic state of the vascular wall may be
involved in AAA growth and rupture. In this regard, Ur-
bonavicius et al31 have recently reported, using proteomics,
reduction in the expression of vitronectin, another cyto-
skeleton-related protein, in ruptured compared to nonrup-
tured AAAs.
It is also important to remark that we cannot herein
discern if the observed decrease in the level of expression of
cytoskeleton and energetic metabolism-related proteins in
AAAs could be related to either reduction in protein ex-
pression and/or to specific proteolytic processes at the
aneurysmal site. In this regard, studies have emphasized the
role of proteinases in AAAs.7,32 However, the expression of
a number of proteins was not changed between AAAs and
control abdominal aortic samples, which may suggest that
independently of the involved mechanism in the control of
protein expression in AAAs, the changes found here in the
expression of proteins at the AAA site were specific.
Age may be a confounding factor in the present study
because control donors were significantly younger than
patients with AAAs. However, the effect of age on the
observed changes in protein expression was discarded by
using age as a covariant in the lineal regression model.
A number of patients with AAAs were taking statins at
inclusion. Statins could potentially affect energetic metab-
olism in terms that reduction of circulating cholesterol may
promote changes in energetic metabolic pathways. Indeed,
statins elevate the rate of -oxidation of long-chain fatty
acids andmitochondrial Kreb’s cycle capacity while it seems
to reduce glycolysis.33 We cannot assess if some of the
control donors were taking statins. However, patients with
AAAs taking and not taking statins at inclusion did not
show differences in the level of expression of proteins that
previously showed to be different between AAAs and con-
trols, which diminished the possible impact of statins on the
present findings.
By keeping to the study design, it is not possible to
determine what is the cellular type of the vascular wall in
which the cytoskeleton and energetic metabolism-related
proteins were changed at the AAA site. Further specific
studies are needed to elucidate it.
In summary, the main finding of the present study was
that the level of expression of proteins associated with the
glycolytic pathway was reduced at the AAA site suggestinghat an anaerobic metabolic state may be favored at the
AA site. Better knowledge of molecular mechanisms in-
olved in AAAs is essential to the full understanding of AAA
rogression and may also favor the development of new
trategies for treatments of the disease.
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